Historians will no doubt look back on 2012 as a watershed year in the evolution of the U.S. healthcare system. If universal health insurance is a hallmark of a modern democracy no different than universal secondary education or universal suffrage, then America still has a long way to go. But the past year's events signaled our country clearly is on a path toward that brighter future.
Related Articles
Our readers noticed that, too. They overwhelmingly chose the U.S. Supreme Court's decision upholding the Patient Protection and Affordable Care Act as the No. 1 news story of the year. Not far behind was the re-election of President Barack Obama, which isn't surprising given his name will be forever linked to the law—dubbed Obamacare—that first enshrined universal coverage as a national goal.
Read the full story: http://bit.ly/ZAHPDB
Source: ModernHealthcare.com
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More